WallStSmart

Coca-Cola Femsa SAB de CV ADR (KOF)vsSRx Health Solutions Inc. (SRXH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola Femsa SAB de CV ADR generates 2288747% more annual revenue ($292.51B vs $12.78M). KOF leads profitability with a 7.9% profit margin vs 0.0%. KOF earns a higher WallStSmart Score of 50/100 (C-).

KOF

Buy

50

out of 100

Grade: C-

Growth: 4.0Profit: 6.5Value: 5.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.49

SRXH

Avoid

19

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 4.0
Piotroski: 2/9Altman Z: -6.89
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOFUndervalued (+50.9%)

Margin of Safety

+50.9%

Fair Value

$229.42

Current Price

$106.47

$122.95 discount

UndervaluedFair: $229.42Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOF3 strengths · Avg: 8.7/10
Return on EquityProfitability
208.3%10/10

Every $100 of equity generates 208 in profit

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$7.63B8/10

Generating 7.6B in free cash flow

SRXH0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

KOF4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.1%4/10

1.1% revenue growth

Profit MarginProfitability
7.9%3/10

7.9% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
22.882/10

Expensive relative to growth rate

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$70.24M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.243/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : KOF

The strongest argument for KOF centers on Return on Equity, Price/Book, Free Cash Flow.

Bull Case : SRXH

SRXH has a balanced fundamental profile.

Bear Case : KOF

The primary concerns for KOF are Revenue Growth, Profit Margin, Piotroski F-Score.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

KOF is growing revenue faster at 1.1% — sustainability is the question.

KOF generates stronger free cash flow (7.6B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KOF scores higher overall (50/100 vs 19/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola Femsa SAB de CV ADR

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola FEMSA, SAB de CV, a franchise bottler, produces, markets, sells and distributes Coca-Cola brand beverages. The company is headquartered in Mexico City, Mexico.

Visit Website →

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?